Cellectar Biosciences Inc

NASDAQ CLRB

Data sourced from iex and EODHD
Download Data

Cellectar Biosciences Inc Income Statement 2005 - 2024

This table shows the Income Statement for Cellectar Biosciences Inc going from 2005 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 2013-03-31 2012-12-31 2012-09-30 2012-06-30 2012-03-31 2011-12-31 2011-09-30 2011-06-30 2011-03-31 2010-12-31 2010-09-30 2010-06-30 2010-03-31 2009-12-31 2009-09-30 2009-06-30 2009-03-31 2008-12-31 2008-09-30 2008-06-30 2008-03-31 2007-12-31 2007-09-30 2007-06-30 2007-03-31 2006-12-31 2006-09-30 2006-06-30 2006-03-31 2005-12-31 2005-09-30 2005-06-30 2005-03-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - 0 - - 0 0 - -
Cost of Revenue
M 0 0 0 0 0 0 - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
Gross Profit
M 0 0 0 0 0 0 - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - 0 0 - -
Operating Expenses
M 12 13 9 8 9 7 - - - - - - - - - - - - - - - 4 3 3 3 4 3 3 3 3 2 2 2 2 2 2 3 2 2 3 3 4 3 3 3 2 2 2 2 2 2 2 1 1 1 1 3 4 2 2 2 2 3 5 7 - - - - - - - - 1 1 - -
Selling, General, and Administrative Expenses (SG&A)
M 5 5 2 2 2 2 2 3 2 2 2 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 0 1 1 1 1 1 1 1 1 1 1 0 2 1 1 0 3 1 1 1 2 1 1 1 0 1 0 -
Research and Development (R&D) Expenses
M 7 8 7 6 7 5 5 4 4 4 4 5 5 2 3 2 3 2 3 2 2 1 2 2 2 3 2 2 2 1 1 1 1 1 1 1 2 1 1 1 2 2 2 2 2 1 1 1 1 1 1 1 1 1 0 0 2 3 2 2 2 2 2 4 7 6 6 4 2 2 2 1 1 0 0 0 -
Other Operating Expenses
M 0 0 0 0 0 0 - - - - - - - - - - - - - - - 2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -2 0 0 0 - - - - - - - - 0 0 - -
Costs and Expenses
M 12 12 9 8 9 7 - - - - - - - - - - - - - - - 2 3 3 3 4 3 3 3 3 2 2 2 2 2 2 3 2 2 2 3 3 3 3 3 2 2 2 2 2 2 2 1 1 1 1 3 - - - - - - - - - - - - - - - - - - - -
Operating Income
M -12 -13 -9 -8 -9 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -4 -3 -3 -3 -4 -3 -3 -3 -3 -2 -2 -2 -2 -2 -2 -3 -2 -2 -3 -3 -4 -3 -3 -3 -2 -2 -2 -2 -2 -2 -2 -1 -1 -1 -1 -3 -4 -2 -2 -2 -2 -3 -5 -7 -7 -7 -4 -3 -3 -3 -2 -1 -1 -1 -3 0
Interest Expense
M - 0 - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - 0 - - - - - - - - - - - - - 0 0 -
Non-operating Income/Expense
M -10 5 -4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -2 0 0 0 0 0 0 0 0 0 0 3 3 0 0 0 0 2 0 0 -1 2 1 -1 0 0 0 0 0 0 -1 0 0 0 0 8 -9 0 -3 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -
EBT
M -22 -8 -14 -8 -9 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -4 -3 -3 -3 -4 -3 -3 -3 -3 -2 -2 1 1 -2 -2 -2 -3 -1 -2 -3 -4 -1 -2 -3 -9 -3 -2 -2 -7 -2 -3 2 0 -2 -2 5 -22 -4 -6 -3 -16 -3 -10 -8 -20 -7 -14 -2 -8 -3 -2 -1 2 -3 -1 0
Income Tax Provision
M - 0 0 - 0 0 0 0 0 0 - - - - - - - - 0 0 0 2 0 0 0 0 0 0 0 0 0 0 -3 -3 0 0 0 0 -2 0 0 1 -2 0 0 -7 0 0 0 -6 0 1 3 0 0 0 -8 -9 0 3 0 -14 0 0 0 -13 0 0 0 -6 0 0 - 0 0 -2 -
Income after Tax
M - -7 -14 - -8 -7 -8 -7 -6 -6 - - - - - - - - -4 -3 -4 -5 -3 -3 -3 -4 -3 -3 -3 -3 -2 -2 4 4 -2 -2 -2 -3 1 -2 -3 -5 0 -2 -3 -2 -3 -2 -2 -2 -2 -3 -1 0 -3 -3 13 -13 -4 -9 -3 -2 -3 -10 -7 -7 -7 -13 -2 -3 -3 -1 - 2 -3 1 -
Non-Controlling Interest
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 2 0 0 1 0 0 0 0 0 0 0 -6 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
Net Income
M - - - -8 -8 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -4 -5 -3 -3 -6 -3 -3 -3 -3 -2 -2 1 1 -2 -2 -2 -3 0 -2 -3 0 0 0 0 0 0 0 0 0 -2 -3 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 29,346,679.00 18,609,907.00 11,308,738.00 11,261,217.00 11,261,217.00 7,055,665.00 6,110,119.00 6,110,124.00 6,110,126.00 5,986,837.00 5,986,837.00 5,276,380.00 4,813,918.00 1,379,355.00 2,632,678.00 1,379,354.00 938,966.00 938,966.00 938,670.00 696,330.00 477,350.00 477,350.00 318,485.00 173,156.00 168,081.00 168,082.00 134,709.00 134,619.00 120,102.00 120,103.00 53,682.00 43,283.00 9,063.00 8,581.00 7,563.00 7,562.00 7,562.00 7,563.00 5,012.00 2,869.00 2,869.00 2,870.00 2,869.00 2,869.00 2,564.00 2,564.00 2,164.00 1,929.00 1,845.00 1,846.00 1,341.00 1,287.00 149.00 1,488.00 36.00 29.00 29.00 30.00 18.00 14.00 14.00 14.00 14.00 12.00 12.00 13.00 12.00 12.00 12.00 13.00 12.00 12.00 12.00 13.00 1,372.00 1,372.00 12.00
EBITDA
M -12 -12 -9 -8 -9 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -1 -3 -3 -3 -3 -3 -3 -3 -3 -3 -2 -5 -4 -2 -2 -3 -2 -4 -3 -3 -2 -4 -3 -3 -2 -2 -2 -2 -2 -2 -1 -2 -1 -1 0 -10 6 -2 1 -3 -2 -3 -5 -7 -7 -7 -4 -3 -3 -3 -2 -1 -1 -1 0 0
Depreciation and Amortization
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 3 -
EBIT
M -12 -13 -9 -8 -9 -7 -8 -7 -6 -6 -6 -6 -6 -4 -4 -4 -4 -3 -4 -3 -4 -1 -3 -3 -3 -4 -3 -3 -3 -3 -3 -3 -5 -4 -2 -2 -3 -2 -4 -3 -3 -2 -5 -3 -3 -2 -2 -2 -2 -2 -2 -1 -2 -1 -1 0 -10 6 -2 1 -3 -2 -3 -5 -7 -7 -7 -4 -3 -3 -3 -2 -1 -1 -1 -3 -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% - 0.80 0.30 - 1.45 0.82 0.05 0.01 0.01 0.02 - - - - - - - - 1.54 1.46 0.23 -42.28 2.41 -0.54 -0.64 0.24 0.38 3.04 -2.74 2.44 7.92 9.38 -342.64 -285.46 7.77 -3.76 12.44 -12.38 349.48 12.22 -4.79 -25.05 121.27 -0.11 -0.08 75.48 0.07 -0.87 -1.31 74.16 0.11 -32.23 128.54 - -13.23 -24.81 -168.26 42.26 -12.41 -48.66 12.61 87.00 0.77 0.42 0.87 66.56 3.38 1.59 5.54 67.74 6.75 13.27 - -2.12 0.20 251.91 -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - - - - - - - - - - - - - - - - - -
Gross Profit Margin
% - 78.82 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 100.00 - - 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - - - - - - 100.00 100.00 - -
Operating Income Margin
% - -3,798.18 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 24,223.86 - - -12,748.86 -12,748.86 -10,908.83 -11,182.53 -30,569.05 -18,500.77 -16,770.14 -6,384.09 -7,197.95 -5,897.20 -7,203.94 -10,326.60 -86,003.44 - - - - - -23,801.65 - - 5,932.72 -7,634.62 - -
Net Income Margin
% - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 0.00 - - 0.00 0.00 0.00 0.00 0.00 - - - - - - - - - - - - - - - - - - - -
EBITDA Ratio
% - -3,777.00 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 23,136.71 - - -18,279.07 -12,719.26 -7,063.72 -5,154.51 -125,014.64 29,577.60 -13,470.68 2,289.64 -8,516.64 -5,889.84 -7,198.43 -10,322.21 -85,988.54 - - - - - -23,791.79 - - 5,929.20 -7,634.46 - -
EBIT Ratio
% - -3,798.18 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 24,879.83 - - -18,308.68 -12,748.86 -7,094.36 -5,190.89 -125,342.13 29,526.22 -13,521.09 2,260.91 -8,536.76 -5,903.38 -7,210.28 -10,331.53 -86,030.43 - - - - - -23,813.57 - - 5,944.63 -7,642.56 - -
EBT Ratio
% - -2,272.83 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - 89,228.63 - - 25,142.69 0.00 -28,721.23 -24,154.81 56,324.10 -115,220.66 -26,171.55 -17,767.08 -10,642.14 -45,140.36 -8,631.23 -21,071.07 -90,050.13 - - - - - -22,782.60 - - -15,613.39 -23,031.22 - -

StockViz Staff

September 20, 2024

Any question? Send us an email